Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenzhen Baoshijian Bioengineering is a specialized biotechnology firm based in China, focusing on the development and production of in vitro diagnostic (IVD) reagents and rapid test kits. Founded in 1992, the company provides a wide range of point-of-care testing (POCT) solutions, including assays for infectious diseases, fertility, drug testing, and oncology. Their manufacturing processes utilize technologies such as colloidal gold chromatography and ELISA to deliver diagnostic tools for both professional and over-the-counter markets. The company is recognized for its contributions to public health diagnostics and maintains a significant presence in the domestic and international medical device sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenzhen Baoshijian Bioengineering.